HK1051503A1 - Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stres s - Google Patents

Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stres s

Info

Publication number
HK1051503A1
HK1051503A1 HK03103853A HK03103853A HK1051503A1 HK 1051503 A1 HK1051503 A1 HK 1051503A1 HK 03103853 A HK03103853 A HK 03103853A HK 03103853 A HK03103853 A HK 03103853A HK 1051503 A1 HK1051503 A1 HK 1051503A1
Authority
HK
Hong Kong
Prior art keywords
reperfusion
ischemia
damage caused
oxidative
stres
Prior art date
Application number
HK03103853A
Other languages
English (en)
Inventor
Klaske Van Norren
Eduard Christiaan Van Hoorn
Hendrik Gerrit Derk Leuvenink
Zandrie Hofman
Original Assignee
Nurtricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nurtricia Nv filed Critical Nurtricia Nv
Publication of HK1051503A1 publication Critical patent/HK1051503A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heat Treatment Of Articles (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
HK03103853A 2000-03-22 2003-05-30 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stres s HK1051503A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201051A EP1136073A1 (en) 2000-03-22 2000-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress
PCT/NL2001/000233 WO2001070248A1 (en) 2000-03-22 2001-03-22 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress

Publications (1)

Publication Number Publication Date
HK1051503A1 true HK1051503A1 (en) 2003-08-08

Family

ID=8171244

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03103853A HK1051503A1 (en) 2000-03-22 2003-05-30 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stres s

Country Status (10)

Country Link
US (2) US20040076692A1 (xx)
EP (2) EP1136073A1 (xx)
JP (1) JP2003527434A (xx)
AT (1) ATE316382T1 (xx)
AU (1) AU2001242876A1 (xx)
DE (1) DE60116860T2 (xx)
DK (1) DK1267901T3 (xx)
ES (1) ES2257401T3 (xx)
HK (1) HK1051503A1 (xx)
WO (1) WO2001070248A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
CA2501719C (en) * 2002-08-06 2013-02-05 Toray Industries, Inc. Remedy or preventive for kidney disease and method of diagnosing kidney disease
DE10257360A1 (de) * 2002-12-09 2004-07-08 Fresenius Kabi Deutschland Gmbh Gastro-intestinal verabreichbare Formulierung und deren Verwendung
FR2854307A1 (fr) * 2003-04-30 2004-11-05 Jean Morelle Utilisation de complements vegetaux d'origine alimentaire, de proprietes anti-stress oxydatif dans le cadre de l'effort physique, humain ou animal
JP2005097222A (ja) * 2003-08-26 2005-04-14 Toyo Shinyaku:Kk タマネギ発酵物
US20070225203A1 (en) * 2003-09-19 2007-09-27 N.V. Nutricia Method and Composition for Preventing Multiple Organ Dysfunction Syndrome
JP4571952B2 (ja) * 2004-02-05 2010-10-27 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー 抗アレルギー組成物及び関連方法
JP2008506785A (ja) 2004-07-21 2008-03-06 フロリダ大学 リサーチファウンデーション インコーポレイティッド インスリン抵抗性の治療及び予防のための組成物及び方法
AU2006222556B2 (en) * 2005-03-11 2011-09-29 Armaron Bio Pty Ltd Flavonoid compounds and uses thereof
AU2006276933A1 (en) * 2005-07-21 2007-02-15 University Of Florida Research Foundation, Inc. Compositions and methods for treatment and prevention of hyperuricemia related health consequences
CN101925361A (zh) * 2008-01-23 2010-12-22 株式会社钟化 植物来源的高尿酸血症的预防或改善剂
WO2009114716A2 (en) * 2008-03-13 2009-09-17 The Regents Of The University Of California Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling
CN102872124B (zh) * 2012-10-27 2013-10-23 南京大学 Houttuynoid A在预防或治疗胰腺纤维化的药物中的应用
CN102872127B (zh) * 2012-10-27 2013-07-17 吴俊华 Houttuynoid C在预防或治疗胰腺纤维化的药物中的应用
JP7401863B2 (ja) * 2020-10-08 2023-12-20 国立大学法人 鹿児島大学 血管攣縮抑制剤、血管攣縮予防剤、血管攣縮予防用経口組成物及び血管攣縮抑制用経口組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2903318B2 (ja) * 1989-04-04 1999-06-07 日研フード株式会社 抗酸化的ストレス物
FR2697159B1 (fr) * 1992-10-22 1995-01-13 Oreal Composition cosmétique ou dermo-pharmaceutique contenant en association un lauroylméthionate d'un amino acide basique et au moins un polyphénol.
FR2699818B1 (fr) * 1992-12-24 1995-02-03 Oreal Composition cosmétique ou pharmaceutique contenant en association un polyphénol et un extrait de gingko.
GB2290487B (en) * 1994-06-23 1998-06-10 John Hunter Dual fuel fluidised bed gasification-combustion system
DE4441279C1 (de) * 1994-11-19 1995-09-21 Abb Management Ag Vorrichtung zur Strombegrenzung
IT1286564B1 (it) * 1996-03-05 1998-07-15 Comiter Trading & Services S R Un prodotto a base di olio extravergine di oliva,olio vergine di oliva od olio di oliva arricchito ed integrato,ed un procedimento per
US5804168A (en) * 1997-01-29 1998-09-08 Murad; Howard Pharmaceutical compositions and methods for protecting and treating sun damaged skin
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5886029A (en) * 1997-09-05 1999-03-23 Dhaliwal; Kirpal S. Method and composition for treatment of diabetes
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
ATE228011T1 (de) * 1998-08-06 2002-12-15 Vascular Biotech Gmbh Wirkstoffkombination insbesondere zur prophylaxe und therapie von ischämischen organschäden und reperfusionssyndromen
CA2348395C (en) * 1998-10-29 2009-12-22 Merck Patent Gesellschaft Mit Beschraenkter Haftung Compositions comprising a mixture of bioflavonols
DE29908634U1 (de) * 1999-04-09 1999-12-16 Hoensch, Harald, Prof.Dr.med., 64521 Groß-Gerau Nahrungsergänzungsmittel zur Behandlung von Darmerkrankungen
WO2000064277A1 (en) * 1999-04-26 2000-11-02 Imperial Sensus, L.L.C. Granular delivery system
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type

Also Published As

Publication number Publication date
EP1267901B9 (en) 2006-06-28
ATE316382T1 (de) 2006-02-15
ES2257401T3 (es) 2006-08-01
JP2003527434A (ja) 2003-09-16
US20040076692A1 (en) 2004-04-22
EP1267901A1 (en) 2003-01-02
EP1267901B1 (en) 2006-01-25
DK1267901T3 (da) 2006-05-29
DE60116860D1 (de) 2006-04-13
WO2001070248A1 (en) 2001-09-27
DE60116860T2 (de) 2006-09-21
AU2001242876A1 (en) 2001-10-03
EP1136073A1 (en) 2001-09-26
US20060270615A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
HK1051503A1 (en) Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stres s
PT935417E (pt) Formulações entéricas de composições poliméricas antidiarreicas de proantocianidina
IL143332A0 (en) Scavenger compounds
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
NZ331104A (en) Phenyl thiazole derivatives that inhibit herpes replication by inhibiting the herpes helicase primase enzyme complex
MY133996A (en) Compounds for the treatment of ischemia
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
ZA9711607B (en) Novel cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
CA2292359A1 (en) Novel azalides and methods of making same
AU2001275228A1 (en) Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
GB2320431B (en) Compositions for the treatment of chronic wounds
WO1997034599A3 (en) Use of clotrimazole and related compounds in the treatment of diarrhea
BR0210744A (pt) Combinação farmacêutica sinergìstica para a prevenção ou tratamento de diabetes
NO20012428L (no) Substituerte kaprolaktamer, farmasöytiske sammensetninger som inneholder dem og deres anvendelse ved behandling av tumorer
PL354959A1 (en) Silicon compounds derived from ascorbic acid
AR006539A1 (es) Derivados de diarilmetilidenfurano, procedimiento para su preparacion y composicion farmaceutica que contiene a dichos derivados.
AR016884A1 (es) Composiciones para el tratamiento del cabello y utilizacion de dicha composicion
EP1068868A3 (en) Synergistic compositions comprising ascorbate and lysine for states related to extracellular matrix degeneration
AU6010599A (en) Prevention and treatment of parodontitis
EP1435901A4 (en) HAIR TREATMENT COMPOSITIONS AND METHOD AND APPARATUS THEREOF
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
BR9812388A (pt) Composição e preparação farmacêutica contendo a mesma para o tratamento de herpes e infecções virais relacionadas
ES2084305T3 (es) Composicion de uso bucal destinada a inhibir o destruir el mal aliento y procedimiento de higiene bucal para destruir el mal aliento.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190326